The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.

The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.
复制标题

DOI:
10.1016/j.ejphar.2013.05.048
复制
发表时间:
2013-09-05
影响因子:
5
通讯作者:
Pitsikas, Nikolaos
Pitsikas, Nikolaos
中科院分区:
医学2区
文献类型:
--
作者:
Grivas, Vasilios;Markou, Athina;Pitsikas, Nikolaos

文献摘要

参考文献

被引文献

相似文献

The activation of Group II metabotropic glutamate 2/3 (mGlu2/3) receptors reduces the excessive glutamate release that is hypothesized to be associated with neurodegenerative and psychiatric disorders. LY379268 is a highly potent mGlu2/3 receptor agonist that has shown efficacy in several animal models of stroke, epilepsy, drug abuse, schizophrenia, and pain. The present study investigated the effects of LY379268 on anxiety-like behavior in rats assessed in the light/dark and open field tests. The effects of LY379268 on motility in a locomotor activity chamber were also investigated in rats. Administration of the two lower doses of LY379268 used (0.3 and 1 mg/kg) did not influence rats’ performance either in the light/dark or in the open field test. Importantly, the administration of a higher LY379268 dose (3 mg/kg) induced decreases in the number of transitions between the light and dark chambers and time spent in the light chamber compared to the vehicle-treated animals in the light/dark test. In the open field test, rats that received 3 mg/kg LY379268 made fewer entries and spent less time in the central zone of the apparatus, exhibited a decrease of rearing episodes, but displayed higher grooming activity compared to controls. Nevertheless, the 3 mg/kg dose did not alter locomotor activity compared with vehicle-treated rats in a motility test. The present results indicate that the highest LY379268 dose used in this study induced an anxiety-like effect in the light/dark and open field tests that cannot be attributed to changes in locomotor activity, while lower doses had not effect.
DOI: 10.1016/0091-3057(87)90006-2
发表时间: 1987-09-01
影响因子: 3.6
作者:
BELZUNG, C;MISSLIN, R;CHAPOUTHIER, G
通讯作者: CHAPOUTHIER, G
DOI: 10.2174/1568007023339337
发表时间: 2002-01-01
影响因子: 3
作者:
Chavez-Noriega, Laura E.;Schaffhauser, Herve;Campbell, Una C.
通讯作者: Campbell, Una C.
DOI: 10.1016/0306-4522(93)90485-x
发表时间: 1993-04-01
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
OHISHI, H;SHIGEMOTO, R;MIZUNO, N
通讯作者: MIZUNO, N